ERBB2 and breast carcinoma: The Cancer Genome Atlas (TCGA), extensive analysis of protein levels, microRNA, and DNA based on the detection of ER, PR, HER2, and low expression proliferating cell nuclear antigen-67 (Ki-67) indicators have helped to establish a more refined subtype of breast cancer.